Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis.
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.
New therapies in the management of rheumatoid arthritis.
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
Efficacy and Safety of GTR in Comparison to Copaxone® (GATE)
A Study of Efficacy and Safety of Ocrelizumab in Patients with Relapse-Remitting Multiple Sclerosis
Improper Inducements
CellCept (Product Insert)
Episode 71 with Dr. Brian Weinshenker on innovative clinical trials for NMO
MS Research Roundup: April 23, 2014
Episode 66 with Dr. Jeremy Hobart on optimizing treatment outcomes
FDA Warns About CCSVI Treatment
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.
Episode 51 with Dr. Luke Lairson on discovery of small molecules to induce remyelination
A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis.
U.S. FDA grants Breakthrough Therapy Designation for Roche’s investigational medicine ocrelizumab in primary progressive multiple sclerosis
Ocrelizumab Bests Interferon in Relapsing-Remitting MS
Gordon Research Conference: Myelin
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison.
CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.
Autoimmunity's next top models.
Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.
Foreseeing the Future?
MS Research Roundup: February 5, 2014

Pages